STOCK TITAN

ChronoScale Holdings Corporation (CHRN) 8-K Filings

CHRN NASDAQ

Ticker history: EKSO became CHRN (ChronoScale Holdings Corporation) on . Earlier news and filings retain their original names and dates. View EKSO history.

Here are the 8-K filings from ChronoScale Holdings Corporation (CHRN) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An 8-K covers material events a company has to report between its quarterly reports, so if you follow CHRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CHRN filings page.

Rhea-AI Summary

ChronoScale Holdings Corporation (CHRN) amended its prior transaction report, adding agreements and supplementing details on a financing and contribution closing. On November 18, 2026, the company closed transactions under its Common Stock Purchase Agreement, issuing approximately 19.1 million common shares for $153.0 million in aggregate gross proceeds and issuing a convertible note to Applied Digital Corporation. It also delivered an initial put notice for Series C preferred shares with a $10.0 million aggregate purchase price.

At the Contribution Closing, OD1 JV Holdings LLC entered a term loan agreement with Macquarie Equipment Capital Inc., became provider under the GPU Services Agreement, and issued a convertible note to ChronoScale Member. ChronoScale issued a warrant to STN and entered an assignment and exchange agreement with APLD Intermediate Holdco LLC.

Rhea-AI Summary

ChronoScale Holdings Corp (CHRN) attached an investor presentation shared with prospective investors in connection with its Common Stock Private Placement. The presentation is dated November 18, 2026 and is incorporated by reference.

Rhea-AI Summary

ChronoScale Holdings Corp. (CHRN) agreed to a common-stock placement of approximately 19.1 million shares at $8.00 each, with expected gross proceeds of $153.0 million and closing expected November 18, 2026. A separate preferred-stock facility permits purchases of up to $500 million, subject to conditions; an initial $10.0 million put was expected. ChronoScale also issued Applied Digital a funded, unsecured $97.0 million convertible note, automatically convertible at $8.00 per share when stockholder approval becomes effective and due December 31, 2026.

The planned Odessa partnership with STN is structured as a 50/50 venture, subject to closing conditions and HSR clearance. ChronoScale's subsidiary is to fund a $220 million partnership note that automatically converts into 50% of partnership units after HSR clearance. The partnership is also to borrow $74,687,500 under a term loan at 10% annual interest, paid in kind and maturing 90 days after closing.

The GPU services agreement has expected contract value of up to $7.5 billion over approximately six years, assuming full performance and delivery of contracted capacity; this excludes extension periods and optional additional tranches. Services are divided into four tranches. A customer may terminate affected tranches for certain delivery delays or sustained service-level failures, with cure rights potentially available.

Rhea-AI Summary

ChronoScale Holdings Corp reported results of its November 6, 2026 annual meeting. Shareholders elected Wes Cummins, Ella Benson, Ying Cenly Chen, William M. Clancy, Douglas Miller, Richard Nottenburg and Andrew Schaap to serve until the 2027 annual meeting, or until a successor is elected and qualified or the director is otherwise unable to complete the term.

Shareholders cast 142,417,127 votes for ratifying CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending May 31, 2027. Advisory executive compensation received 141,001,650 votes for and 53,135 against; ratification of certain restricted stock awards to non-employee directors received 140,412,964 for and 642,461 against. The adjournment proposal received 141,565,630 votes for and 815,179 against.

Rhea-AI Summary

ChronoScale Holdings Corporation (CHRN) reported fiscal first-quarter 2027 revenue of $41.5 million for the quarter ended August 31, 2026, up 148% from $16.7 million in the prior-year comparable period. Net loss from continuing operations was $26.4 million, compared with $11.2 million in fiscal first quarter 2026; adjusted EBITDA, a non-GAAP measure, was $5.9 million versus $9.4 million. Cash and cash equivalents were $15.2 million as of August 31, 2026.

ChronoScale secured a 50 MW AI compute deployment with Microsoft in North America and entered strategic partnerships with Nutanix and Baseten. The three-year Baseten partnership supports a planned deployment of approximately 4 MW, with completion expected in calendar Q1 2027. ChronoScale received $328.2 million in aggregate prepayments under existing customer contracts and said it was on track for $1 billion in annualized run-rate revenue by calendar Q3 2027; that operating metric is based on current assumptions, is not a forecast of revenue for any specific reporting period, and actual revenue may differ materially.

On September 30, 2026, ChronoScale completed the sale of the Legacy Ekso Business. Its results were excluded from continuing operations and reported separately as discontinued operations; net loss from discontinued operations was $16.1 million.

Rhea-AI Summary

ChronoScale Holdings Corporation disclosed that Scott Davis, a member of its Board and CEO of Ekso Bionics, Inc., resigned from the Board effective October 3, 2026, following the September 30, 2026 sale of Ekso. The company stated that there were no disagreements with Davis leading to his resignation.

On October 2, 2026, ChronoScale granted Davis 51,626 restricted stock units, which fully vested that day, and entered into a Release Agreement providing for a $709,500 lump-sum cash payment, less applicable withholdings and deductions. The payment is subject to Davis’s compliance with the agreement and his continuing restrictive covenants, and is payable within 30 days of execution. The agreement is in lieu of and in full satisfaction of any payment or benefit under a Change in Control and Severance Agreement; it does not amend the separate Phantom Performance-Based Restricted Stock Unit Agreement.

Rhea-AI Summary

ChronoScale Holdings Corp (symbol: CHRN) is the issuer of record for a Form 8-K filing submitted to the SEC.

Rhea-AI Summary

ChronoScale Holdings Corporation (CHRN) reports that its wholly owned subsidiary ChronoScale Intermediate, LLC, as borrower, and Ekso Bionics, Inc., as guarantor, entered into a First Amendment to their Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC.

The underlying term loan has an aggregate principal amount of up to $2.0 million, all of which was outstanding as of the amendment date. The amendment extends the loan’s time-based maturity to November 12, 2026 and specifies that a sale of the guarantor on the terms described in the amendment will be treated as a Permitted Disposition. All other material terms of the original agreement remain in effect.

Rhea-AI Summary

ChronoScale Holdings Corporation (CHRN) reported that it has entered into a strategic AI infrastructure partnership with Microsoft for a planned 50-megawatt (MW) AI compute deployment in North America. The deployment is expected to use NVIDIA GB300 NVL72 systems with advanced liquid-cooling, high-performance networking, storage, and purpose-built data center infrastructure to support large-scale AI training and inference workloads.

The company also disclosed that the term of its previously announced strategic partnership with Microsoft has been extended from two years to three years, reflecting a longer planned collaboration around this AI compute deployment. ChronoScale positions its platform as an accelerated compute environment purpose-built for demanding AI workloads and emphasizes that numerous risks and uncertainties, including integration of its recently completed business combination, capital access, and cloud compute industry growth, could affect actual outcomes versus current expectations.

Rhea-AI Summary

ChronoScale Holdings Corp (CHRN) disclosed a new Offer of Continued Employment for Jerome Wong, Chief Financial Officer of subsidiary ChronoScale Corporation, effective August 16, 2026. The agreement sets an annual base salary of $400,000 and eligibility for an annual performance bonus targeted at 60% of base salary, plus a cash “true-up” for the period from May 5, 2026 through August 16, 2026.

Mr. Wong is also contemplated to receive 300,000 restricted stock units (RSUs) with time-based vesting, approved by the board’s Compensation Committee. Upon a Qualifying CIC Termination during the Change in Control Period, he would receive cash severance equal to nine months of base salary, up to nine months of subsidized health coverage, and accelerated vesting of the initial RSU tranche. If later terminated without Cause outside that context, he would receive cash severance equal to six months of base salary, paid as salary continuation, in each case subject to a release of claims and ongoing compliance with restrictive covenants.

Rhea-AI Summary

ChronoScale Corporation filed Amendment No. 2 to its current report to add detailed financial statements for its Applied Digital Cloud (“Cloud”) business and pro forma results following the recent Business Combination. Cloud provides GPU-based cloud services and has grown quickly but remains loss‑making and capital intensive.

For the fiscal year ended May 31, 2025, Cloud generated $84.4 million in revenue, up sharply from $29.0 million a year earlier, yet recorded a net loss of $72.7 million and operating loss of $55.3 million. For the nine months ended February 28, 2026, revenue was $53.2 million with a net loss of $32.8 million, reflecting the loss of a customer and heavy lease and interest expenses.

The filings highlight significant lease obligations and prior working capital deficits, with Cloud historically relying on its former parent for financing. Management discloses that substantial doubt about continuing as a going concern was raised but believes this has been alleviated through lease renegotiations, strong operating cash flow in the latest nine-month period, and a $15.8 million private placement completed alongside the Business Combination.

Rhea-AI Summary

ChronoScale Corporation reported governance changes, appointing Andrew Cordell Schaap to its board of directors and increasing the board size from seven to eight members, effective June 29, 2026. He will serve on the Audit Committee, replacing Douglas Miller, and on the Related Party Transactions Committee.

Upon his appointment, Mr. Schaap received a Restricted Stock Award covering 200,000 shares of common stock under the 2026 Omnibus Equity Incentive Plan. The award vests in two equal annual installments on the first and second anniversaries of the grant date, subject to continued service, with certain acceleration conditions described in the award agreement.

The company also outlined the refreshed composition of its Audit, Compensation, Nominating and Governance, and Related Party Transaction committees as of June 30, 2026, and filed the related Restricted Stock Award Agreement as an exhibit.

Rhea-AI Summary

ChronoScale Corporation entered into an unsecured Demand Grid Promissory Note with Applied Digital Corporation, creating a revolving line of credit with a maximum principal amount of $100,000,000, reduced by any credit support Applied Digital or its affiliates provide to ChronoScale and its affiliates.

The company may draw on this line for working capital and general corporate purposes, but no amounts have been borrowed yet. Interest on any outstanding balance will accrue at the short-term Applicable Federal Rate, compounded semiannually, and the note can be prepaid at any time without penalty. The lender can demand repayment in full, and the note is not convertible into ChronoScale common stock.

Applied Digital and its affiliate APLD ChronoScale HoldCo LLC collectively hold approximately 96% of ChronoScale’s outstanding common stock, and several directors serve on both companies’ boards. The note was approved by the Related Party Committees of both boards under their related party policies.

Rhea-AI Summary

ChronoScale Corporation announced that its Board approved a plan on May 29, 2026 to divest its wholly owned subsidiary, Ekso Bionics, Inc., and concentrate operations solely on its cloud business.

The company expects to complete the Ekso divestiture during the first fiscal quarter. It anticipates material charges related to severance costs, lease termination payments, transaction expenses, and other exit costs. ChronoScale has not yet determined reliable estimates for these charges and plans to amend the report within four business days after setting those estimates, as required.

Rhea-AI Summary

ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., is amending previously disclosed phantom performance-based stock unit awards for three senior executives. The awards, granted on November 5, 2025, totaled 185,000 Phantom PSUs for Scott G. Davis, 40,000 for Jerome Wong, and 32,000 for Jason Jones.

The Board determined on May 14, 2026 that the stock price goal was achieved and that the May 5, 2026 closing of a Contribution and Exchange Agreement constituted a Change in Control, satisfying vesting conditions. Settlement has been changed from cash-only to equity and cash.

Mr. Davis’s award will now settle in 109,357 shares of common stock plus a $1,000,000 cash payment, while Mr. Wong and Mr. Jones will receive 40,000 and 32,000 shares of common stock, respectively. Payments and share issuances will occur after the closing and no later than March 15, 2027.